208 related articles for article (PubMed ID: 18034345)
21. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
[TBL] [Abstract][Full Text] [Related]
22. WT1 protein expression in slowly proliferating myeloid leukemic cell lines is scarce throughout the cell cycle with a minimum in G0/G1 phase.
Kerst G; Bergold N; Viebahn S; Gieseke F; Kalinova M; Trka J; Handgretinger R; Müller I
Leuk Res; 2008 Sep; 32(9):1393-9. PubMed ID: 18457871
[TBL] [Abstract][Full Text] [Related]
23. miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level.
Gao SM; Xing CY; Chen CQ; Lin SS; Dong PH; Yu FJ
J Exp Clin Cancer Res; 2011 Dec; 30(1):110. PubMed ID: 22133358
[TBL] [Abstract][Full Text] [Related]
24. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
[TBL] [Abstract][Full Text] [Related]
25. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.
Krug U; Yasmeen A; Beger C; Bäumer N; Dugas M; Berdel WE; Müller-Tidow C
Int J Oncol; 2009 Jan; 34(1):129-36. PubMed ID: 19082485
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis of leukemic cells by TRUE gene silencing using small guide RNAs targeting the WT1 mRNA.
Watanabe N; Narita M; Yamahira A; Taniguchi T; Furukawa T; Yoshida T; Miyazawa T; Nashimoto M; Takahashi M
Leuk Res; 2013 May; 37(5):580-5. PubMed ID: 23403166
[TBL] [Abstract][Full Text] [Related]
27. Down-regulatory mechanism of mammea E/BB from Mammea siamensis seed extract on Wilms' Tumor 1 expression in K562 cells.
Rungrojsakul M; Katekunlaphan T; Saiai A; Ampasavate C; Okonogi S; Sweeney CA; Anuchapreeda S
BMC Complement Altern Med; 2016 May; 16():130. PubMed ID: 27193767
[TBL] [Abstract][Full Text] [Related]
28. Effects of Curcuma spp. on P-glycoprotein function.
Ampasavate C; Sotanaphun U; Phattanawasin P; Piyapolrungroj N
Phytomedicine; 2010 Jun; 17(7):506-12. PubMed ID: 19879740
[TBL] [Abstract][Full Text] [Related]
29. WT1 regulates cyclin A1 expression in K562 cells.
Pandey S; Moazam M; Ghimirey N; Kuerbitz SJ; Fraizer GC
Oncol Rep; 2019 Nov; 42(5):2016-2028. PubMed ID: 31436300
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
[TBL] [Abstract][Full Text] [Related]
31. Effects of bufalin on up-regulating methylation of Wilm's tumor 1 gene in human erythroid leukemic cells.
Wang LP; Zhao YN; Sun X; Gao RL
Chin J Integr Med; 2017 Apr; 23(4):288-294. PubMed ID: 28364352
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds.
Glienke W; Chow KU; Bauer N; Bergmann L
Leuk Lymphoma; 2006 Aug; 47(8):1629-38. PubMed ID: 16966277
[TBL] [Abstract][Full Text] [Related]
33. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines.
Liu YL; Yang HP; Gong L; Tang CL; Wang HJ
Mol Med Rep; 2011; 4(4):675-9. PubMed ID: 21484077
[TBL] [Abstract][Full Text] [Related]
34. Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.
Renshaw J; Orr RM; Walton MI; Te Poele R; Williams RD; Wancewicz EV; Monia BP; Workman P; Pritchard-Jones K
Mol Cancer Ther; 2004 Nov; 3(11):1467-84. PubMed ID: 15542786
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.
Guillaumet-Adkins A; Richter J; Odero MD; Sandoval J; Agirre X; Catala A; Esteller M; Prósper F; Calasanz MJ; Buño I; Kwon M; Court F; Siebert R; Monk D
J Hematol Oncol; 2014 Jan; 7():4. PubMed ID: 24405639
[TBL] [Abstract][Full Text] [Related]
36. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
[TBL] [Abstract][Full Text] [Related]
37. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids.
Limtrakul P; Anuchapreeda S; Buddhasukh D
BMC Cancer; 2004 Apr; 4():13. PubMed ID: 15090070
[TBL] [Abstract][Full Text] [Related]
38. Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer.
Wright LE; Frye JB; Gorti B; Timmermann BN; Funk JL
Curr Pharm Des; 2013; 19(34):6218-25. PubMed ID: 23448448
[TBL] [Abstract][Full Text] [Related]
39. [Transcriptional activity of WT1 gene promoter and enhancer in diverse cell lines].
Hu SY; Chen ZX; Zhao Y; Cen JN; Gu M; Fu ZZ; He J; Gu WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1050-5. PubMed ID: 17956689
[TBL] [Abstract][Full Text] [Related]
40. Vasodilating, spasmolytic, inotropic and chronotropic activities of curcuminoids from Curcuma longa in isolated organ preparations of guinea pigs.
Jamil QUA; Iqbal SM; Jaeger W; Studenik C
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
